1977
DOI: 10.1016/0014-2999(77)90038-3
|View full text |Cite
|
Sign up to set email alerts
|

Propranolol in doca hypertensive rats: Development of hypertension inhibited and pressor responsiveness enhanced

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1979
1979
1992
1992

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(4 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…Another drug with selective but weak antihypertensive effects that could be centrally mediated is propranolol. 28 Because identical blood pressure levels can be produced in normotensive and DOCA hypertensive rats by cutting the spinal cord at the C6-C7 level, 23 but not by destroying the posterior hypothalamus, 11 sympathetic nerve hyperactivity may be occurring at sites on the neuraxis lower than the posterior hypothalamus. Thus, the apparent contradiction between enhanced pressor responsiveness to hypothalamic stimulation 10 on the one hand, and the lack of a greater hypotensive effect upon hypothalamic destruction 11 on the other, would be resolved.…”
Section: Discussionmentioning
confidence: 99%
“…Another drug with selective but weak antihypertensive effects that could be centrally mediated is propranolol. 28 Because identical blood pressure levels can be produced in normotensive and DOCA hypertensive rats by cutting the spinal cord at the C6-C7 level, 23 but not by destroying the posterior hypothalamus, 11 sympathetic nerve hyperactivity may be occurring at sites on the neuraxis lower than the posterior hypothalamus. Thus, the apparent contradiction between enhanced pressor responsiveness to hypothalamic stimulation 10 on the one hand, and the lack of a greater hypotensive effect upon hypothalamic destruction 11 on the other, would be resolved.…”
Section: Discussionmentioning
confidence: 99%
“…In mature spontaneously hypertensive rats, propranolol has been reported to lower (Roba, Lambelin & de Schaepdryver, 1972) or to have no effect on (Forman & Mulrow, 1974, Buniag, 1977 systolic BP, and to lower (Garvey & Ram, 1975) to raise (Nakao, Kato & Takagi, 1975) or to have no effect on (Weiss, Lundgren & Folkow, 1974;Conway, Darwin Hilditch, Loveday & Reeves, 1975) mean arterial BP. Furthermore, it has been found that pretreatment with propranolol may either not affect (Frohlich & Pfeffer, 1975) or may prevent (Weiss et al, 1975) the development of the spontaneous hypertension.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, it has been found that pretreatment with propranolol may either not affect (Frohlich & Pfeffer, 1975) or may prevent (Weiss et al, 1975) the development of the spontaneous hypertension. There are reports of either a reduction (Dusting & Rand, 1974, Buniag, 1977 or no change (Farmer & Levy, 1968) in the systolic BP of deoxycorticosterone acetate (DOCA)-saline hypertensive rats, and the mean arterial BP of such hypertensive animals has been reported not to change after propranolol treatment (Conway et al, 1975). However, it is generally agreed 0007-1188/79/020205-09 $01.00 that pre-loading with propranolol does prevent the development of hypertension in young rats with DOCA implants given saline to drink (Conway et al, 1975;Bufiag, 1977).…”
Section: Introductionmentioning
confidence: 99%
“…A test dose of 1.6 mg/100g was used routinely since the bradycardia it produces had previ ously been shown to be maximal and unaf fected by further increases in dose (5). Unlike mecamylamine, propranolol caused consistent bradycardia but affected systolic pressure ir regularly.…”
Section: Sympathetic Hyperactivity In Enovid-treated Renal Hypertensimentioning
confidence: 99%